Detalhe da pesquisa
1.
Concomitant use of a dual Src/ABL kinase inhibitor eliminates the in vitro efficacy of blinatumomab against Ph+ ALL.
Blood
; 137(7): 939-944, 2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32898857
2.
CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group.
Blood
; 138(13): 1137-1147, 2021 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951732
3.
CD43-positive, EWSR1::FLI1 -rearranged Soft Tissue Sarcoma in a Pediatric Patient With History of B-Cell Acute Lymphoblastic Leukemia.
J Pediatr Hematol Oncol
; 45(5): e635-e638, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37027334
4.
Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.
Proc Natl Acad Sci U S A
; 117(25): 14331-14341, 2020 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32513686
5.
Chemotherapy roadmaps in pediatric oncology: A digital electronic medical record integrated solution.
J Oncol Pharm Pract
; 28(8): 1722-1730, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34558367
6.
IFN-γ and CD38 in AML: a T-cell engagement made in heaven?
Blood
; 143(16): 1556-1557, 2024 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635257
7.
CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells.
Blood
; 133(6): 588-599, 2019 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30425048
8.
Pediatric Hodgkin Lymphoma, Version 3.2021.
J Natl Compr Canc Netw
; 19(6): 733-754, 2021 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34214968
9.
CREBBP alterations are associated with a poor prognosis in de novo AML.
Blood
; 141(17): 2156-2159, 2023 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634304
10.
INSPIRED Symposium Part 4A: Access to CAR T Cell Therapy in Unique Populations with B Cell Acute Lymphoblastic Leukemia.
Transplant Cell Ther
; 30(1): 56-70, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37821078
11.
Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium.
Cancers (Basel)
; 16(3)2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339248
12.
Drug-regulated CD33-targeted CAR T cells control AML using clinically optimized rapamycin dosing.
J Clin Invest
; 134(9)2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502193
13.
INSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia.
Transplant Cell Ther
; 29(11): 674-684, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37689393
14.
Access to Chimeric Antigen Receptor T Cell Clinical Trials in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult Acute Lymphobastic Leukemia Patients.
Transplant Cell Ther
; 29(6): 356.e1-356.e7, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36966871
15.
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies.
Leukemia
; 37(9): 1767-1778, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37452102
16.
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.
Blood Adv
; 7(4): 575-585, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35482927
17.
Bryostatin Activates CAR T-Cell Antigen-Non-Specific Killing (CTAK), and CAR-T NK-Like Killing for Pre-B ALL, While Blocking Cytolysis of a Burkitt Lymphoma Cell Line.
Front Immunol
; 13: 825364, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35222407
18.
CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group.
J Clin Oncol
; 40(3): 252-261, 2022 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34855461
19.
Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL.
J Clin Oncol
; 40(9): 932-944, 2022 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34767461
20.
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome.
Nat Commun
; 12(1): 1334, 2021 02 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33637765